Brain organic cation transporter 2 controls response and vulnerability to stress and GSK3β signaling

Thomas Couroussé(Délégation Paris 5), Sophie Gautron(Inserm), A-M Le Guisquet(Inserm), Catherine Belzung(Université de Tours), Alfred H. Schinkel(Oncode Institute), Bruno P. Guiard(Université Paris-Sud), Alain M. Gardier(Université Paris-Saclay), Laure Balasse(Institut National de la Recherche Agronomique), Alexandre Bacq(Inserm), Franck Louis(Centre National de la Recherche Scientifique), Bruno Giros(Centre National de la Recherche Scientifique)
Molecular Psychiatry
August 5, 2014
10.1038/mp.2014.86
Cited by 62

Related Papers

Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics
|Nature|1990|2.6k
Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter
|Nature|1996|2.5k
Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs
|Cell|1994|2.3k
Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism
|Nature Genetics|2003|1.8k
Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins
|Proceedings of the National Academy of Sciences|1997|941